Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by 64cudotatate And 18ffdg

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07671118Active Not Recruiting

Endocarditis Clinical Awareness, Research, and Evaluation in Sweden

NCT05432427Not ApplicableCompleted

64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis.

Showing all 2 trials

Research Network

Common Treatments

  • 64cudotatate And 18ffdg1

Active Sponsors

  • Emil Loldrup Fosbol1
  • Karolinska Institutet1

Top Investigators

Related Conditions

  • Endocarditis Bacterial1
  • Endocarditis Acute And Subacute1
  • Endocarditischronic1
  • Endocarditis1
  • Endocarditis Infective1

Activity Timeline